O'Brien M J, Kirkham S E, Burke B, Ormerod M, Saravis C A, Gottlieb L S, Neville A M, Zamcheck N
Invest Cell Pathol. 1980 Jul-Sep;3(3):251-8.
Carcinoembryonic antigen (CEA), the zinc glycinate marker (ZGM) and epithelial membrane antigen (EMA) have been described as epithelial or tumour markers of varying specificity. These antigens were studied by immunoperoxidase localization in selected cell blocks of 62 pleural or peritoneal effusions and compared to cytological findings and review of the clinical records. By cytological criteria, 25 of the cell blocks were positive for malignancy, 30 negative, and 7 inconclusive. CEA, ZGM, and EMA by immunoperoxidase staining were localized on the cell surface and often in the cytoplasm of malignant cells, in 11/25 (44 per cent), 17/25 (68 per cent) and 22/25 (88 per cent) of the positive cell blocks respectively. Ten (40 per cent) of these cases were positive for all three antigens, 7 (28 per cent) for two, and 6 (24 per cent) for one. Of the 7 cases which were inconclusive on routine cytological reporting, 5 were positive for at least one marker. In 3 of the 5 a diagnosis of malignancy was confirmed, and in the other two was strongly suspected as malignant on clinical grounds. Macrophages were sometimes positive for one or more markers (but showed cytoplasmic staining only) and mesothelial cells in some cases stained positively for EMA but were always negative for CEA and ZGM. Localization of the 3 antigens in cells of malignant effusions was compared with their localization in the primary tumours in 9 cases. Localization corresponded for CEA in 7 of 9 cases, for EMA in 8 of 8 an for ZGM in only 2 of 9. Effusion fluid levels for CEA were compared with the cytological and immunocytochemical findings in 30 cases. Mucin stains performed on the cell blocks were also compared with the immunoperoxidase findings.
癌胚抗原(CEA)、甘氨酸锌标记物(ZGM)和上皮膜抗原(EMA)已被描述为具有不同特异性的上皮或肿瘤标志物。通过免疫过氧化物酶定位法对62例胸腔或腹腔积液的选定细胞块中的这些抗原进行了研究,并与细胞学检查结果及临床记录回顾进行了比较。根据细胞学标准,25个细胞块为恶性阳性,30个为阴性,7个为不确定。通过免疫过氧化物酶染色,CEA、ZGM和EMA分别定位于11/25(44%)、17/25(68%)和22/25(88%)阳性细胞块的恶性细胞表面,且常位于细胞质中。这些病例中有10例(40%)三种抗原均为阳性,7例(28%)为两种抗原阳性,6例(24%)为一种抗原阳性。在7例常规细胞学报告不确定的病例中,5例至少有一种标志物呈阳性。在这5例中的3例中确诊为恶性肿瘤,另外2例根据临床情况强烈怀疑为恶性。巨噬细胞有时对一种或多种标志物呈阳性(但仅显示细胞质染色),间皮细胞在某些情况下对EMA呈阳性染色,但对CEA和ZGM始终为阴性。将3种抗原在恶性积液细胞中的定位与9例原发性肿瘤中的定位进行了比较。9例中有7例CEA定位相符,8例中有8例EMA定位相符,9例中只有2例ZGM定位相符。对30例病例的CEA积液水平与细胞学和免疫细胞化学检查结果进行了比较。还将细胞块上进行的黏液染色与免疫过氧化物酶检查结果进行了比较。